Pharmacovigilance (PV) Market Size

1. The search results reveal comprehensive market research reports about the global pharmacovigilance (PV) market from Fortune Business Insights, covering market size, growth projections, key players, and industry trends through 2032. Key findings from the latest report include:  Market size: USD 8.32 billion in 2024  Projected growth: USD 23.45 billion by 2032  CAGR: 14.0% (2025-2032)  Regional dominance: North America with 40.75% market share in 2024  Europe holds substantial market share  Asia Pacific expected to see fastest growth The reports analyze:  Market segmentation by type (services and software)  Deployment models (in-house and outsource)  End users (Contract Research Organizations, pharmaceutical companies, others)  Regional analysis covering North America, Europe, Asia Pacific, Latin America, Middle East & Africa Key market drivers identified:  Growing adverse drug reactions (ADRs) reporting  Increasing outsourcing by pharmaceutical companies  Rising adoption of AI-powered solutions  Expanding clinical trials and vaccine development Leading companies profiled include:  IQVIA Inc.  Laboratory Corporation of America Holdings  Accenture  Cognizant  Ergomed Group  Parexel International Corporation Recent Developments:  February 2024: Ergomed's PrimeVigilance acquired Panacea to expand global presence  November 2023: Accenture partnered with Salesforce to integrate AI capabilities  April 2023: Parexel International Corporation collaborated with Partex for AI-powered drug development solutions Report- Fortune Business Insights - Pharmacovigilance Market Size, Share & Trends | Growth [2032] https://www.fortunebusinessinsights.com/pharmacovigilance-pv-market-102746